506 related articles for article (PubMed ID: 17117018)
1. Varicella vaccination in HIV-1-infected children after immune reconstitution.
Bekker V; Westerlaken GH; Scherpbier H; Alders S; Zaaijer H; van Baarle D; Kuijpers T
AIDS; 2006 Nov; 20(18):2321-9. PubMed ID: 17117018
[TBL] [Abstract][Full Text] [Related]
2. Immunogenicity of a two-dose regime of varicella vaccine in children with cancers.
Leung TF; Li CK; Hung EC; Chan PK; Mo CW; Wong RP; Chik KW
Eur J Haematol; 2004 May; 72(5):353-7. PubMed ID: 15059071
[TBL] [Abstract][Full Text] [Related]
3. Administration of live varicella vaccine to HIV-infected children with current or past significant depression of CD4(+) T cells.
Levin MJ; Gershon AA; Weinberg A; Song LY; Fentin T; Nowak B;
J Infect Dis; 2006 Jul; 194(2):247-55. PubMed ID: 16779732
[TBL] [Abstract][Full Text] [Related]
4. Persistent humoral immune defect in highly active antiretroviral therapy-treated children with HIV-1 infection: loss of specific antibodies against attenuated vaccine strains and natural viral infection.
Bekker V; Scherpbier H; Pajkrt D; Jurriaans S; Zaaijer H; Kuijpers TW
Pediatrics; 2006 Aug; 118(2):e315-22. PubMed ID: 16847077
[TBL] [Abstract][Full Text] [Related]
5. Immune response induced by live attenuated varicella vaccine and short term follow-up on immunity of the vaccinated children.
Chiba Y; Miura J; Kumagai T; Nakao T
Biken J; 1984 Sep; 27(2-3):67-71. PubMed ID: 6100061
[TBL] [Abstract][Full Text] [Related]
6. The incidence of zoster after immunization with live attenuated varicella vaccine. A study in children with leukemia. Varicella Vaccine Collaborative Study Group.
Hardy I; Gershon AA; Steinberg SP; LaRussa P
N Engl J Med; 1991 Nov; 325(22):1545-50. PubMed ID: 1658650
[TBL] [Abstract][Full Text] [Related]
7. Restoration of varicella-zoster virus cell-mediated immune response after varicella booster vaccination.
Berger R; Luescher D; Just M
Postgrad Med J; 1985; 61 Suppl 4():143-5. PubMed ID: 3014472
[TBL] [Abstract][Full Text] [Related]
8. Lack of transmission of the live attenuated varicella vaccine virus to immunocompromised children after immunization of their siblings.
Diaz PS; Au D; Smith S; Amylon M; Link M; Smith S; Arvin AM
Pediatrics; 1991 Feb; 87(2):166-70. PubMed ID: 1846236
[TBL] [Abstract][Full Text] [Related]
9. Varicella-zoster virus infection in Romanian children infected with the human immunodeficiency virus.
Leibovitz E; Cooper D; Giurgiutiu D; Coman G; Straus I; Orlow SJ; Lawrence R
Pediatrics; 1993 Dec; 92(6):838-42. PubMed ID: 7901834
[TBL] [Abstract][Full Text] [Related]
10. Measles antibody in vaccinated human immunodeficiency virus type 1-infected children.
Arpadi SM; Markowitz LE; Baughman AL; Shah K; Adam H; Wiznia A; Lambert G; Dobroszycki J; Heath JL; Bellini WJ
Pediatrics; 1996 May; 97(5):653-7. PubMed ID: 8628602
[TBL] [Abstract][Full Text] [Related]
11. Loss of varicella zoster virus antibodies despite detectable cell mediated immunity after vaccination.
Ludwig B; Kraus FB; Allwinn R; Keim S; Doerr HW; Buxbaum S
Infection; 2006 Aug; 34(4):222-6. PubMed ID: 16896582
[TBL] [Abstract][Full Text] [Related]
12. Prevention and treatment of VZV infections in patients with HIV.
Gershon AA
Herpes; 2001 Jul; 8(2):32-6. PubMed ID: 11867015
[TBL] [Abstract][Full Text] [Related]
13. T lymphocyte cytotoxicity with natural varicella-zoster virus infection and after immunization with live attenuated varicella vaccine.
Diaz PS; Smith S; Hunter E; Arvin AM
J Immunol; 1989 Jan; 142(2):636-41. PubMed ID: 2536059
[TBL] [Abstract][Full Text] [Related]
14. Low induction of varicella-zoster virus-specific secretory IgA antibody after vaccination.
Terada K; Niizuma T; Yagi Y; Miyashima H; Kataoka N; Sadahiro T
J Med Virol; 2000 Sep; 62(1):46-51. PubMed ID: 10935988
[TBL] [Abstract][Full Text] [Related]
15. [Active chickenpox vaccination of children with acute leukemia or other neoplastic diseases].
Haas RJ; Belohradsky B; Dickerhoff R; Eichinger K; Eife R; Holtmann H; Goetz O; Graubner U; Peller P
Klin Padiatr; 1985; 197(6):477-80. PubMed ID: 3003449
[TBL] [Abstract][Full Text] [Related]
16. Immunization of children with malignant diseases with the Oka-strain varicella vaccine.
Austgulen R
Postgrad Med J; 1985; 61 Suppl 4():93-5. PubMed ID: 3014485
[TBL] [Abstract][Full Text] [Related]
17. Active immunization against varicella of children with acute leukaemia or other malignancies on maintenance chemotherapy.
Haas RJ; Belohradsky B; Dickerhoff R; Eichinger K; Eife R; Holtmann H; Goetz O; Graubner U; Peller P
Postgrad Med J; 1985; 61 Suppl 4():69-72. PubMed ID: 3014480
[TBL] [Abstract][Full Text] [Related]
18. Safety and immunogenicity of live varicella virus vaccine in children with human immunodeficiency virus type 1.
Armenian SH; Han JY; Dunaway TM; Church JA
Pediatr Infect Dis J; 2006 Apr; 25(4):368-70. PubMed ID: 16567993
[TBL] [Abstract][Full Text] [Related]
19. Humoral and cell-mediated immune responses in children and adults after 1 and 2 doses of varicella vaccine.
Watson B
J Infect Dis; 2008 Mar; 197 Suppl 2():S143-6. PubMed ID: 18419388
[TBL] [Abstract][Full Text] [Related]
20. Clinical application of a live varicella vaccine (Oka strain) in a hospital.
Naganuma Y; Osawa S; Takahashi R
Biken J; 1984 Sep; 27(2-3):59-61. PubMed ID: 6100059
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
